CME Information
Overview
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by an educational grant from Kala Pharmaceuticals, Inc.
Target Audience
The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with dry eye disease.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize the burden of dry eye disease in both symptomatic and asymptomatic patient populations to better understand the need for treatment.
- Differentiate the mechanisms of action for conventional versus novel therapies for dry eye disease.
- Compare the efficacy of conventional dry eye therapies with newer options for treatment.
- Assess the efficacy and safety of new therapies for their ability to treat both the signs and symptoms of dry eye disease.
Actvity Chair
Edward J. Holland, MD
Director of Cornea
Cincinnati Eye Institute
Professor of Clinical Ophthalmology
University of Cincinnati
Edgewood, KY
Faculty
Marjan Farid, MD
Clinical Professor of Ophthalmology
Director of Cornea, Cataract and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA
Preeya K. Gupta, MD
Managing Director
Triangle Eye Consultants
Durham, NC
Francis S. Mah, MD
Director, Cornea Service
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, CA
Contributing Faculty
Terry Kim, MD
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer
Valerie Zimmerman, PhD
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.
Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.
This enduring material is approved for 1 year from the date of original release, March 10, 2022, to March 10, 2023.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Farid, Gupta, Holland, and Mah during a satellite symposium held on November 14, 2021. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Actvity Chair and Faculty report the following relevant financial relationship(s)
Marjan Farid, MD
Advisor: Allergan, Bausch + Lomb, Bio-Tissue, Dompé, J&J Vision, Novartis, Orasis
Consultant: Allergan, Bausch + Lomb, Bio-Tissue, Dompé, J&J Vision, Novartis, Orasis
Preeya K. Gupta, MD
Consultant: Alcon, Allergan, HanAll, J&J Vision, Kala, New World Medical, Novartis, Ocular Therapeutix, Orasis, Oyster Point, Sight Sciences, Surface Ophthalmics, Inc., Sun Ophthalmics, TearLab, TissueTech, Zeiss
Individual Stocks and Stock Options: Surface Ophthalmics, Inc.
Edward J. Holland, MD
Consultant: Aerie, Alcon, Aldeyra, Allegro, Allergan, Aramis Biosciences, Azura, BRIM Biotechnology, Dompé, Eyevance, EyeYon, Glaukos, Guidepoint Global, HanAll, J&J Vision, Kala, LifeSci Capital, Mati, Mimetogen, Novartis, Ocular Therapeutix, Oculis SA, Orasis, Oyster Point, Physician Recommended Nutriceuticals, Senju, Sight Sciences, SilkTech, Surface OphthalmicsPharmaceuticals, VivaVision
Independent Research Contractor: AbbVie, Aerie, Alcon, Bausch + Lomb, Dompé, Mati, Novartis, Oyster Point, Senju, Surface Pharmaceuticals, VivaVision
Individual Stocks and Stock Options: Azura, EyeYon, Glaukos, Invirsa, Kala, Mati, Mimetogen, Orasis, Oyster Point, Sight Sciences, SilkTech, Stuart Therapeutics, Surface OphthalmicsPharmaceuticals, TearLab, Visionology
Francis S. Mah, MD
Consultant: Aerie, Alcon, Aldeyra, Allergan, Aperta, Azura, Bausch + Lomb, Dompé, EyeGate, Eyevance, EyeYon, Glaukos, iView, J&J Vision, Kala, Novartis, NuLids, Ocular Therapeutix, Oyster Point, Sight Sciences, Sun, TearLab, Théa
Individual Stocks and Stock Options: Aperta, EyeGate, iView
Contributing Faculty reports the following relevant financial relationship(s)
Terry Kim, MD
Relevant Financial Disclosures
Consultant: Aerie, Alcon, Allergan, Azura Ophthalmics,
Bausch + Lomb, Dompè, J&J Vision, Kala, Novartis,
Ocular Therapeutix, Oculis, Sight Sciences, Surface Ophthalmics
Individual Stocks and Stock Options: Kala,
Ocular Therapeutix, Omeros
Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com